News & Media :: Vedanta Biosciences, Inc.

Feb 6, 2019

Positive selection: Careful sorting of probiotics may finally pave the way for an FDA approval

Recent News

Jan 23, 2019

Vedanta Biosciences Publishes Seminal Research in Leading Scientific Journal for its Immuno-oncology Candidate, VE800

Dec 24, 2018

Vedanta Biosciences Raises $27 Million Series C Financing to Advance Clinical Pipeline of Microbiome-Derived Product Candidates

Dec 17, 2018

Vedanta Biosciences Initiates Phase 2 Study for Lead Rationally-Defined Bacterial Consortium Product Candidate, VE303

Dec 10, 2018

Bristol-Myers Squibb and Vedanta Biosciences Announce a New Clinical Collaboration to Evaluate OPDIVO® (nivolumab) and VE800 in Patients with Advanced or Metastatic Cancers

View All News View All Press Releases